# EDGAR Filing Document

**Accession Number:** 0001837493
**File Stem:** 0001185185-26-001275
**Filing Date:** 2026-4
**Character Count:** 118053
**Document Hash:** 110a59640733e4032f4644fda0c0e8e1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001185185-26-001275.hdr.sgml**: 20260406

**ACCESSION NUMBER**: 0001185185-26-001275

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20260406

**FILED AS OF DATE**: 20260406

**DATE AS OF CHANGE**: 20260406

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Inspira Technologies OXY B.H.N. Ltd
- **CENTRAL INDEX KEY:** 0001837493
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40303
- **FILM NUMBER:** 26839649

**BUSINESS ADDRESS:**
- **STREET 1:** HATIDHAR 2
- **STREET 2:** 11TH FLOOR
- **CITY:** RA'ANANA
- **STATE:** L3
- **ZIP:** 4366504
- **BUSINESS PHONE:** 972-9-9664488

**MAIL ADDRESS:**
- **STREET 1:** HATIDHAR 2
- **STREET 2:** 11TH FLOOR
- **CITY:** RA'ANANA
- **STATE:** L3
- **ZIP:** 4366504

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the Month of April 2026**

**Commission File Number: 001-40303**

**Inspira Technologies Oxy B.H.N. Ltd.**

**(Translation of registrant's name into English)**

**2 Ha-Tidhar St.**

**Ra'anana 4366504, Israel**

**(Address of principal executive office)**

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

**<u>CONTENTS</u>**

*Asset Purchase Agreement and Transaction*

On April 1, 2026, Inspira Technologies Oxy B.H.N. Ltd. (the "Company") entered into an Asset Purchase Agreement (the "Agreement") with Nano Dimension Technologies Ltd. (the "Seller"), pursuant to which the Company agreed to acquire certain assets comprising the Seller's additive manufacturing electronics business and Fabrica business (collectively, the "Assets"). The Assets to be acquired include the Seller's intellectual property, equipment, tooling, books and records, inventory, transferred customer contracts and leasehold rights and accounts receivable. The transaction contemplated by the Agreement closed on April 6, 2026.

The total potential consideration payable for the Assets is up to $12,500,000 and consists of: (i) a cash payment of $2,000,000, payable at the closing; and (ii) potential deferred consideration of up to $10,500,000 (the "Deferred Consideration") is based on net cash proceeds collected during the 12-month period following the closing (the "Deferred Consideration Period"). The Deferred Consideration will consist of: (i) 50% of net cash proceeds collected as part of the Assets, up to a maximum amount of $4,000,000; and (ii) 50% of aggregate Fabrica net cash proceeds, up to a maximum amount of $6,500,000. For purposes of the Deferred Consideration, net cash proceeds is equal to the cash actually collected, net of certain expenses, tax, and commissions. Pursuant to the terms of the Agreement, the Company will be required to deliver quarterly statements within 30 days after each three-month period, with a final true-up and payment within 30 days following the conclusion of the Deferred Consideration Period. The closing is subject to customary conditions, including: (i) delivery of corporate approvals; (ii) execution of intellectual property assignment instruments; and (iii) the receipt of third party's approvals or the transfer of research and development programs.

The foregoing description of the Agreement set forth above is qualified in its entirety by reference to the full text of the Agreement attached hereto as Exhibit 10.1 to this Report of Foreign Private Issuer on Form 6-K (this "Report").

The Agreement and the foregoing description thereof, have been included to provide investors and shareholders with information regarding the terms of the Agreement. Any assertions in the representations and warranties contained in the Agreement are qualified by information in confidential disclosure schedules delivered by each of the Company and the Seller to the other party, respectively, in connection with the signing of the Agreement. Moreover, certain representations and warranties in the Agreement were made as of a specified date, may be subject to a contractual standard of materiality different from what might be viewed as material to shareholders, or may have been used for the purpose of allocating risk between the parties to the Agreement. Accordingly, the representations and warranties in the Agreement should not be relied on by any persons as characterizations of the actual state of facts and circumstances of the Company at the time they were made and should be considered in light of the entirety of the factual disclosure about the Company in the Company's public reports filed with the Securities and Exchange Commission (the "SEC"). Information concerning the subject matter of the representations and warranties may change after the date of the Agreement, which subsequent information may or may not be fully reflected in the Company's public disclosures.

A copy of the press release related to the acquisition entitled "Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension" is furnished as Exhibit 99.1 hereto and is incorporated by reference herein.

This Report is incorporated by reference into the Company's Registration Statements on Form F-3 (Registration Nos. [333-284308](http://www.sec.gov/Archives/edgar/data/1837493/000121390025004023/ea0227763-f3_inspira.htm) and [333-289324](http://www.sec.gov/Archives/edgar/data/1837493/000121390025072618/ea0251967-f3_inspira.htm)) and Form S-8 (Registration Nos. [333-259057](http://www.sec.gov/Archives/edgar/data/1837493/000121390021044780/ea146415-s8_inspiratech.htm), [333-277980](http://www.sec.gov/Archives/edgar/data/1837493/000121390024023044/ea0201791-s8_inspira.htm), [333-285565](http://www.sec.gov/Archives/edgar/data/1837493/000121390025020699/ea0233153-s8_inspira.htm), [333-290162](http://www.sec.gov/Archives/edgar/data/1837493/000121390025086563/ea0254938-s8_inspira.htm) and [333-292592](http://www.sec.gov/Archives/edgar/data/1837493/000121390026001862/ea0272007-s8_inspira.htm)), filed with the SEC, to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

*Forward Looking Statements*

This Report contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, the Company is using forward-looking statements when it discusses the expected purchase and closing of the Agreement and receipt of the Assets from the Seller; and the consideration payable for the acquired Assets. Because such statements deal with future events and are based on the Company's current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of the Company could differ materially from those described in or implied by the statements in this Report. The forward-looking statements contained or implied in this Report are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in the Company's Annual Report on Form 20-F, filed with the SEC on March 26, 2026, and in subsequent filings with the Securities and Exchange Commission (the "SEC"). Except as otherwise required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events or circumstances or otherwise.

---

| | |
|:---|:---|
| **Exhibit No.** | |
| 10.1 | [Asset Purchase Agreement, dated April 1, 2026, by and between Inspira Technologies Oxy B.H.N. Ltd. and Nano Dimension Technologies Ltd.](iinnex10-1.htm) |
| 99.1 | [Press Release issued by Inspira Technologies Oxy B.H.N. Ltd. on April 6, 2026, titled "Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension."](iinnex99-1.htm) |

---

**<u>SIGNATURES</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **Inspira Technologies Oxy B.H.N. Ltd.** | **Inspira Technologies Oxy B.H.N. Ltd.** | **Inspira Technologies Oxy B.H.N. Ltd.** |
| Date: April 6, 2026 | By: | /s/ Dagi Ben-Noon | /s/ Dagi Ben-Noon |
|  |  | Name: | Dagi Ben-Noon |
|  |  | Title: | Chief Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**ASSET PURCHASE AGREEMENT**

This Asset Purchase Agreement (this "**Agreement**") is entered into as of April 1, 2026 (the "**Effective Date**") by and between Nano Dimension Technologies Ltd. ("**NNDM**", or "**Seller**"), and Inspira Technologies Oxy B.H.N. Ltd. ("**Company**", or "**Buyer**"). Seller and Buyer are each referred to herein as a "**Party**," and together as "**Parties**."

 **RECITALS**

**WHEREAS**, Buyer desires to purchase, and Seller desires to sell, certain assets comprising Seller's Business (as defined below), on the terms and subject to the conditions set forth in this Agreement;

**WHEREAS**, Seller desires to sell, and Buyer desires to acquire, the Purchased Assets (as defined below) on an "as-is, where-is" basis, subject only to the express terms of this Agreement, and except for the Fundamental Representations expressly set forth herein, Buyer is not relying on any representation or warranty of Seller, whether express or implied, regarding the Purchased Assets, the Business, or any other matter;

**NOW, THEREFORE,** in consideration of the foregoing and of the mutual promises contained in this Agreement, the Parties hereby agree as follows:

**AGREEMENT <br> DEFINITIONS AND CONSTRUCTION**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1. Definitions

Capitalized terms used herein have the meanings set forth in this Agreement. The following terms have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.1** **"Accounts Receivable"** means any AME Account Receivable and/or any Fabrica Accounts
Receivable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.2** "**AME Accounts Receivable**" means accounts receivable attributable to the AME Business
and listed in Annex 2.1.5, together with all rights, claims, causes of action and collections related thereto, and together with all liabilities,
obligations, services, support obligations, warranty obligations, credits, offsets, returns, rebates, claims and other obligations relating
thereto, whether arising prior to, on or after the Closing Date, unless expressly identified as an Excluded Liability in Annex 2.2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.3** **"Fabrica Accounts Receivable**" means accounts receivable attributable to the Fabrica
Business and listed in  **<u>Annex 2.1.5</u>** , together with all rights, claims, causes of action and collections related thereto,
and together with all liabilities, obligations, services, support obligations, warranty obligations, credits, offsets, returns, rebates,
claims and other obligations relating thereto, whether arising prior to, on or after the Closing Date, unless expressly identified as
an Excluded Liability in  **<u>Annex 2.2</u>** .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.4** "**Affiliate(s)**" means, with respect to any Person, any other Person directly or indirectly
controlling, controlled by, or under common control with such Person.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.5** "**AME Business**" means Seller's additive manufacturing electronics (AME) business
and related operations, limited to the Purchased Assets and Assumed Liabilities as of Closing, and expressly excluding the Excluded Assets
and Excluded Liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.6** "**Assumed Liabilities**" has the meaning set forth in Section 2.2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.7** "**Business**" means the AME Business and the Fabrica Business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.8** "**Business Day**" means a day other than a Saturday, Sunday, or other day on which commercial
banks in Tel Aviv, Israel are authorized or required by Law to be closed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.9** "**Closing**" means the consummation of the transactions contemplated by this Agreement
in accordance with Section 2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.10** "**Closing Date**" means the date on which Closing occurs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.11** "**Customer Advances**" means all amounts received by Seller prior to the Closing from
customers as advance payments, prepayments or deposits in connection with the Transferred Customer Contracts or otherwise relating to
the Business, as expressly set forth in  **<u>Annex 1.1.11</u>** .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.12** "**Deferred Consideration**" means the additional purchase price payable pursuant to Section
5.1.2 plus applicable VAT.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.13** "**Deferred Consideration Period**" means the twelve (12) month period beginning on the
Closing Date and ending at the end of the full twelve (12) months thereafter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.14** "**Earn-Out Statement**" means a statement prepared by Buyer and reviewed by Buyer's
independent auditors setting forth AME Net Cash Proceeds, Fabrica Net Cash Proceeds and the resulting Deferred Consideration for each
applicable period and in the aggregate, together with reasonable supporting detail and backup documentation sufficient to verify the calculations
therein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.15** "**Encumbrance**" means any lien, pledge, charge, security interest, mortgage, deed of
trust, claim, option, right of first refusal, right of first offer, restriction, easement, encroachment, or other encumbrance of any kind.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.16** "**Excluded Assets**" has the meaning set forth in Section **‎** 2.3.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.17** "**Excluded Liabilities**" means the liabilities relating to the Business that are expressly
set forth in  **<u>Annex 2.3</u>** .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.18** "**Fabrica Business**" means Seller's Nano Fabrica business and related operations,
limited to the Purchased Assets and Assumed Liabilities as of Closing, and expressly excluding the Excluded Assets and Excluded Liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.19** "**Governmental Authority**" means any governmental, regulatory, administrative, tax, judicial,
arbitral or other authority, agency, commission, board or body (national, federal, state, local or foreign).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.20** "**Government Contract**" means any Transferred Contract to which a Governmental Authority
is a party or otherwise is a beneficiary of any rights thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.21** "**Key Personnel**" means the employees of Seller identified by Buyer in writing prior
to Closing, to whom Buyer intends to extend employment offers following Closing; *provided, however*, that Key Personnel shall not
constitute Purchased Assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.22** "**Intellectual Property**" means all intellectual property and proprietary rights in any
jurisdiction, including patents, patent applications, invention disclosures, trade secrets, know-how, copyrights, software, firmware,
mask works, design rights, database rights, trademarks and domain names.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.23** "**Inventory**" means the AME Inventory and the Fabrica Inventory.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.24** "**AME Inventory**" means the finished goods, work-in-process and raw materials relating
to the AME Business transferred to Buyer at Closing pursuant to Section 2.1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.25** "**Fabrica Inventory**" means the finished goods, work-in-process and raw materials relating
to the Fabrica Business transferred to Buyer at Closing pursuant to Section 2.1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.26** "**IIA**" means the Israel Innovation Authority.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.27** "**Law**" means any applicable law, statute, ordinance, rule, regulation, order, judgment,
decree or other requirement of any Governmental Authority.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.28** "**AME Net Cash Proceeds**" means cash amounts (x) invoiced and actually collected during
the Deferred Consideration, or (y) invoiced during the Deferred Consideration Period and actually collected within six (6) months thereafter,
in each case in respect of (i) sales, lease, consignment or other transfer of the transferred AME Inventory; and (ii) collections of AME
Accounts Receivable for sale concluded and/or services provided by Seller prior to Closing, net only of: (a) returns, credits and discounts
actually granted in the ordinary course and consistently applied; (b) shipping, handling, VAT, sales tax and/or duties actually borne
in respect of such invoiced or collected amounts; and (c) third-party sales commissions actually paid to unaffiliated third parties in
respect of such invoiced or collected amounts. For the avoidance of doubt, Buyer shall not take any action, omit to take any action, alter
pricing, defer invoicing, accelerate credits, reallocate revenues, bundle products or services, or otherwise manipulate the operation
of the AME Business or the Purchased Assets, in each case with the purpose or reasonably foreseeable effect of reducing AME Net Cash Proceeds,
the Fabrica Net Cash Proceeds or Deferred Consideration. Buyer shall operate the transferred Business and the Purchased Assets in a commercially
reasonable manner consistent with past practices.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.29** "**Fabrica Net Cash Proceeds**" means cash amounts: (x) invoiced and actually collectedduring
the Deferred Consideration Period, or (y) invoiced during the Deferred Consideration Period and actually collected within six (6) months
thereafter, in each case in respect of collections of Fabrica Accounts Receivable for sale concluded and/or services provided by Seller
prior to Closing, net only of: (a) returns, credits and customary discounts actually granted in the ordinary course and consistently applied;
(b) shipping, handling, VAT, sales tax and/or duties actually borne in respect of such invoiced or collected amounts; and (c) third-party
sales customary commissions actually paid to unaffiliated third parties in respect of such invoiced or collected amounts. For the avoidance
of doubt, Buyer shall not take any action, omit to take any action, alter pricing, defer invoicing, accelerate credits, reallocate revenues,
bundle products or services, or otherwise manipulate the operation of the Fabrica Business or the Purchased Assets, in each case with
the purpose or reasonably foreseeable effect of reducing Fabrica Net Cash Proceeds. Buyer shall operate the transferred Fabrica Business
and the Purchased Assets in a commercially reasonable manner consistent with past practices.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.30** "**Permits**" means all permits, licenses, approvals, authorizations, consents, registrations,
certificates and exemptions required under applicable Law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.31** "**Person**" means any individual, corporation, partnership, limited liability company,
association, trust or other entity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.32** "**Post-Closing Assistance Period**" means the period commencing on the Closing Date and
ending on the date that is two (2) months thereafter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.33** "**Purchased Assets**" has the meaning assigned to it in Section 2.1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.34** "**Software**" means any and all computer software, documentation, code and other materials,
including assemblers, applets, compilers, source code, source code listings, object code, algorithms, data (including image and sound
data), manuals, instructions, samples, examples, content, charts, diagrams, design tools and user interfaces, in any form or format, however
fixed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.35** "**Third Party Software**" means any Software that is a component of or necessary to compile
the Transferred Software and that is not owned by Seller.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.36** "**Trade Control Laws**" means (a) Section 721 of the Defense Production Act of 1950, as
amended (50 U.S.C. 4565), and its implementing regulations (including 31 C.F.R. Parts 800 and 802); (b) the International Traffic in Arms
Regulations (ITAR) (22 C.F.R. Parts 120-130); (c) the Export Administration Regulations (EAR) (15 C.F.R. Parts 730-774), including the
anti-boycott provisions set forth in 15 C.F.R. Part 760; (d) the regulations administered by the U.S. Department of the Treasury Office
of Foreign Assets Control (OFAC) (31 C.F.R. Chapter V); and (e) the Israeli Defense Export Control Law, 2007, the Israeli Order of Import
and Export (Control of Export of Dual Use Goods, Services and Technologies), 2006, the Order Governing the Control of Commodities and
Services (Engagement in Encryption), 1974, and the Israeli Trading with the Enemy Ordinance, 1939, in each case together with all regulations
and orders promulgated thereunder or issued by virtue thereof, as amended from time to time, and any successor or supplemental legislation,
regulations, or orders applicable to the Company or any of its subsidiaries

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.37** "**Trade Control Triggering Rights**" means any of the following, to the extent such rights
constitute "control," "material nonpublic technical information," "critical technology," "sensitive
personal data," or "covered investment critical infrastructure," in each case as such term is defined under applicable
Trade Control Laws: (i) "control"; (ii) access to any "material nonpublic technical information" (as such term
is defined under applicable Trade Control Laws) in the possession of the Company or any of its subsidiaries; (iii) membership or observer
rights on the Board of Directors or equivalent governing body of the Company or any of its subsidiaries, or the right to nominate an individual
to a position on any such Board or equivalent governing body of the Company or any of its subsidiaries; or (iv) any involvement, other
than through the voting of shares, in substantive decision-making of the Company or any of its subsidiaries regarding (x) the use, development,
acquisition, or release of any Company critical technology" (as defined under applicable Tade Control Laws); (y) the use, development,
acquisition, safekeeping, or release of "sensitive personal data" (as defined under applicable Tade Control Laws) of U.S.
citizens maintained or collected by the Company or any of its subsidiaries, or (z) the management, operation, manufacture, or supply of
"covered investment critical infrastructure" (as defined under applicable Tade Control Laws).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.38** "**Transferred Contracts**" means those contracts expressly listed in  **<u>Annex 2.1.4</u>** .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.39** "**Transferred Intellectual Property Rights** ", or the "**Transferred IP** "
means the Intellectual Property Right transferred to Buyer pursuant to Section 2.1.1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.40** "**Transferred Software**" means all proprietary Software developed and owned by Seller
as of the Closing Date, related to, used in or necessary for the operation of the AME Business, as further set forth in and expressly
listed in **Annex 2.1.1**, together with the related documentation expressly listed therein, including the Transferred Third Party
Software, related to, used in or necessary for the operation of the AME Business. For the avoidance of doubt, (i) no Transferred Third
Party Software, off-the-shelf software, SaaS subscriptions, hosted software, or other commercially available software shall constitute
Transferred Software and/or the Purchased Assets unless expressly listed in Annex 2.1.1.1, and (ii) Buyer shall be solely responsible
for procuring any Third Party Software or off-the-shelf software required for the use or operation of the Purchased Assets following Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.41** "**Transferred Third Party Software**" means all Seller's rights to the Third-Party
Software listed in **Annex 2.1.1.1** hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1.42** "**Yissum Agreement**" means the license agreement by and between the Seller and and Yissum
Research Development Company of the Hebrew University of Jerusalem, dated September 16, 2014 (as amended).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2 Construction

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.2.1** The singular number will include the plural, and vice versa; the masculine gender will include the feminine
and neuter genders; the feminine gender will include the masculine and neuter genders; and the neuter gender will include the masculine
and feminine genders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.2.2** Any rule of construction to the effect that ambiguities are to be resolved against the drafting Party
will not be applied in the construction or interpretation of this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.2.3** The words "include" and "including" and variations thereof, will not be deemed
to be terms of limitation, but rather will be deemed to be followed by the words "without limitation;"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.2.4** Except as otherwise indicated, all references in this Agreement to "Sections", "Subsections"
and "Annexes" are intended to refer to Sections or Subsections of this Agreement and Annexes to this Agreement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.2.5** The headings in this Agreement are for convenience of reference only, will not be deemed to be a part
of this Agreement, and will not be referred to in connection with the construction or interpretation of this Agreement.

2 SALE, TRANSFER AND ASIGNMENT OF THE PURCHASED ASSETS, EXCLUDED ASSETS, RELATED TRANSACTIONS

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 Sale and Transfer of Assets.

Subject to the terms and conditions of this Agreement, at the Closing Seller shall sell, assign, convey, transfer and deliver to Buyer, and Buyer shall purchase and acquire from Seller, free and clear of all Encumbrances, Seller's right, title and interest in and to the Purchased Assets expressly listed in **<u>Annex 2.1</u>**, on an "as-is, where-is" basis and subject only to the express terms of this Agreement. In furtherance of the foregoing, Seller shall (i) irrevocably grant, convey and assign to the Buyer all of its worldwide right, title and interest in and to the Purchased Assets, to be held and enjoyed by the Buyer and its successors and assigns; and (ii) further irrevocably grant, convey and assign to the Buyer all of its worldwide right, title and interest in and to any and all causes of action and rights of recovery for past infringement or misappropriation of the Transferred Intellectual Property Rights, to be held and enjoyed by Buyer and its successors and assigns, and the Buyer shall accept the foregoing grants, conveyances and assignments. For the avoidance of doubt, the Purchased Assets shall consist solely of the assets expressly identified in **<u>Annex 2.1</u>** and the corresponding sub-annexes.

(collectively, the "**Purchased Assets**"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.1.1** <u>Intellectual Property and Know-How</u>: the Intellectual Property expressly listed in  **<u>Annex 2.1.1</u>** including the specific proprietary Software, know-how, patents, patent applications, invention disclosures, trade secrets, design rules,
process documentation, CAD files, process recipes, firmware and software and engineering documentation, as set forth in  **<u>Annex 2.1.1</u>** hereto, in each case specifically excluding any customers' Intellectual Property (the "**Transferred Intellectual Property Rights** ", or the "**Transferred IP** "). Seller shall have no post-Closing obligation to create, reconstruct,
explain, supplement or otherwise provide any additional know-how not expressly delivered at Closing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.1.2** <u>Equipment and Tooling; Books and Records:</u> the equipment and tooling used in Business expressly
set forth in  **<u>Annex 2.1.2</u>** hereto and all technical documentation, quality and manufacturing records, test reports, certifications
and related books and records expressly listed in  **<u>Annex 2.1.2</u>** .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.1.3** <u>Inventory:</u> Inventory as of Closing, expressly set forth in  **<u>Annex 2.1.3;</u>** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.1.4** <u>Transferred Contracts:</u> transferable customer contracts/POs (to the extent assignable), and related
relationship/pipeline documentation, leasehold rights, and other contracts in each case expressly listed in in  **<u>Annex 2.1.4</u>** hereto (the "**Transferred Customer Contracts**") and any other contract specifically assumed by the Buyer and specified
as such in  **<u>Annex 2.1.4 (a)</u>** including, for the avoidance of doubt, the Transferred Leasehold. Any contract not expressly
listed in  **<u>Annex 2.1.4</u>** shall be deemed an Excluded Asset. Any customer contract expressly identified in  **<u>Annex 2.1.4</u>** for which third party consent is required and has not been obtained as of Closing, shall be subject to a temporary transition arrangement
and handled exclusively in accordance with  **<u>Annex 2.1.4</u>** and Section ‎7.3;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.1.5** <u>Accounts Receivables:</u> the account receivables listed in  **<u>Annex 2.1.5</u>** , attributable
to the Business together with all underlying rights, claims and collections, and together with all related liabilities, obligations, credits,
returns, rebates, support obligations, warranty obligations and other obligations relating thereto, except to the extent expressly identified
as Excluded Liabilities in  **<u>Annex 2.3</u>** ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.1.6** <u>Leasehold Rights:</u> Seller's leasehold rights in connection with that certain real property
in Ness Ziona for purposes of operations of the Business, as set forth in  **<u>Annex 2.1.6</u>** (the "**Transferred Leasehold** ");
provided, however, that (i) Buyer shall be solely responsible, at its sole cost and expense, for obtaining any landlord consent required
for the assignment or transfer of the Transferred Leasehold, (ii) the obtaining of such consent shall not be a condition to Closing, (iii)
Buyer shall bear and be solely responsible for any payments, fees, charges, penalties or other amounts required by the landlord or any
third party in connection with or arising out of such consent or the transfer of the Transferred Leasehold, (iv) as of Closing, Buyer
shall assume the Transferred Leasehold and all liabilities and obligations arising thereunder from and after Closing, and (v) from and
after Closing, Seller shall have no liability whatsoever to the landlord or otherwise in respect of the Transferred Leasehold, and Buyer
shall indemnify and hold Seller harmless from and against any and all liabilities, obligations, claims, losses, damages and expenses arising
out of or relating to the Transferred Leasehold from and after Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 Assumption of Liabilities.

Without derogating from the provisions of Section 2.1 and subject to all terms and conditions of this Agreement, at the Closing, Buyer shall assume and agree to pay, perform and discharge solely the following liabilities (the "**Assumed Liabilities"**) all liabilities, obligations and commitments associated with, or relating to the transferred operations of the Business and/or the Purchased Assets arising before closing and all such liabilities, obligations and commitments associated with, or relating to the transferred operations of the Business and/or the Purchased Assets arising after Closing, in each case except to the extent expressly identified as Excluded Liabilities under Section 2.3, **<u>Annex 2.3</u>** and **<u>Annex 2.3.8</u>**, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.2.1** all obligations arising under or relating to the Transferred Customer Contracts, Accounts Receivables,
Inventory, transferred services, support obligations, warranty obligations, customer claims, credits, offsets, rebates, returns and collections,
arising before Closing, to the extent relating to the Purchased Assets or the transferred Business and all obligations arising under or
relating to the Transferred Customer Contracts, Accounts Receivables, Inventory, transferred services, support obligations, warranty obligations,
customer claims, credits, offsets, rebates, returns and collections, arising after Closing; in each case except to the extent expressly
identified as Excluded Liabilities in  **<u>Annex 2.3</u>** ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.2.2** Customer Advances: Without limiting the generality of the foregoing, Buyer acknowledges and agrees that,
with respect to any Customer Advances, Buyer shall be solely responsible, from and after the Closing, for the fulfillment, performance
and delivery of all products, inventory and services corresponding thereto, and for all liabilities and obligations arising out of or
relating thereto, whether arising prior to, on or after the Closing. For the avoidance of doubt, such obligations shall constitute Assumed
Liabilities in all respects, and Buyer shall have no right to any reimbursement, adjustment or claim against Seller in respect thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.2.3** the liabilities, obligations, royalties, restrictions, undertakings and commitments including, without
limitation, to the IIA, to Yissum under the Yissum Agreement and to any other governmental authorities related liabilities, R&D grants,
programs, approvals or undertakings associated with the Purchased Assets or the transferred Business, arising after the Closing, as further
set forth in  **<u>Annex 2.2.3</u>** hereto; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.2.4** the liabilities under the Transferred Leasehold.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3 Excluded Assets

Notwithstanding anything to the contrary herein, the Purchased Assets shall not include, and Seller shall retain, the following assets (collectively, the "**Excluded Assets**"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.3.1** Corporate level assets, cash, cash equivalents, bank accounts, securities and other assets of Seller,
whether or not related to the AME Business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.3.2** Tax refunds, Tax attributes and any rights to receive refunds or credits for Taxes attributable to periods
ending on or before Closing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.3.3** Intercompany receivables not directly tied to the transferred Business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.3.4** Personnel files and records, except to the extent legally required to be transferred or shared, subject
to Law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.3.5** NNDM personnel, including Key Personnel, and any liabilities towards personnel retained by Company, as
accrued prior to the Closing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.3.6** All assets not expressly included in the Purchased Assets (and for the avoidance of doubt, no asset shall
be included by implication, operation of law or reference to the Business generally);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.3.7** Any non-transferable contracts/licenses or rights deemed to be required by Company, for which required
consents are not obtained at Closing, until required consents are obtained and unless otherwise expressly addressed in  **<u>Annex 2.1.4</u>** and Section ‎7.3; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.3.8** any assets set forth in  **<u>Annex 2.3.8.</u>** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4 Further Assurances

During the Post-Closing Assistance Period only, Seller will, upon reasonable written request and at Buyer's expense, use commercially reasonable efforts to take such actions and execute and deliver such documents as may be reasonably required in order to effect and perfect the grants, conveyances and assignments contained herein, to enable the Buyer to obtain the full benefits of this Agreement and the transactions contemplated hereby, or to otherwise enforce or protect the Transferred Intellectual Property Rights and all other Purchased Assets:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.4.1** deliver to the Buyer records, data or other documents relating to the Transferred Intellectual Property
Rights that are in Seller's possession;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.4.2** deliver to the Buyer records, data or other documents relating to end users that are in Seller's
possession;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.4.3** execute and deliver assignments, licenses, consents, documents or further instruments of transfer, and
consent to the filing of the sole applications, including without limitation the short form assignments to be agreed between the Parties
prior to Closing and thereafter attached as Annex  **<u>‎2.4.3</u>** ; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.4.4** take other reasonable actions, render other assistance and execute other documents as are reasonably necessary
to effect the specific transfers contemplated by this Agreement; provided that Seller shall not be required to incur any out-of-pocket
cost, assume any liability, provide transition services, or undertake any substantive business activity, without its prior written consent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5 Exclusive Ownership

At the Closing, subject to the terms and conditions of this Agreement, Buyer shall acquire whatever right, title and interest Seller has in and to the Purchased Assets as of Closing, on an "as-is, where-is" basis and without any representation or warranties except as expressly set forth herein. Without limitation from the generality of the foregoing, as of the Closing Date, Buyer will have the exclusive and unlimited right to publish any information concerning the Purchased Assets and the Business, to commercialize, prepare and sell products based upon, license, sublicense, prepare derivative works from, transfer to third parties, change, alter and otherwise exploit the Transferred Assets and any and all Transferred IP. Seller hereby waives any and all moral rights, including any right to identification of authorship or limitation on subsequent modification, which Seller (or its employees, agents or consultants) has or may have in any Purchased Assets. To the extent, if any, that Seller retains any right to the Transferred Software (excluding any Transferred Third Party Software), Seller hereby grants and agree to grant to the Buyer a perpetual, exclusive, irrevocable, fully paid-up, royalty free, transferable, sublicensable, worldwide right and license under any rights Seller may have to use, make, reproduce, distribute, display and perform, modify, sell, and otherwise exploit and distribute in any manner, all or any portion of such Transferred Software, in any form or media.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.6 Power of Attorney

As of the Closing, Seller irrevocably designates and appoints the Buyer to act on its behalf and instead of Seller in order to execute and file any such application, and to do all other lawfully permitted acts to further the prosecution and issuance of Transferred Intellectual Property Rights provided for herein with the same legal force and effect as if executed by Seller. This power of attorney shall be deemed coupled with an interest, shall be irrevocable and shall survive the Closing without any time limitation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.7 Assumption of Liabilities; Retention of Liabilities

At the Closing, subject to the terms and conditions of this Agreement, Buyer shall assume all Assumed Liabilities, including (i) all liabilities related to the Purchased Assets; and (ii) without derogating from (i) above, the liabilities to the IIA as set forth in Section ‎2.8.5‎ (the "**IIA Liabilities**"), and any and all liabilities in connection with the Yissum Agreement arising from the Closing onwards (together, the "**Assumed Liabilities**"); Except for the Excluded Liabilities as set forth above in, Seller shall not retain any liability relating to the Purchased Assets or the transferred Business starting as of the Closing.

---

| | |
|:---|:---|
| **2.7A** | **No Post-Closing Seller Obligations**. Except as expressly set forth in this Agreement, Seller shall have no liability or obligation whatsoever from and after the Closing with respect to the Purchased Assets or the Business, including toward any customers, vendors, counterparties, landlords, governmental authorities, employees or any other third party, whether arising by contract, law or otherwise. Without limiting the generality of the foregoing, all liabilities and obligations arising out of or relating to the Purchased Assets or the Business from and after the Closing shall be solely for the account of Buyer. Without limiting the foregoing, Seller shall have no liability whatsoever in respect of any Customer Advances or the fulfillment of any related products, inventory or services, and Buyer shall be solely responsible therefor and shall indemnify and hold Seller harmless from and against any and all claims, liabilities, losses, damages and expenses arising therefrom. |

---

---

| | |
|:---|:---|
| **2.7B** | **Closing.** The closing of the transactions contemplated by this Agreement (the "**Closing**") shall take place via the electronic exchange of execution versions of the agreements and documents contemplated hereby via email by .pdf, or at such other place or such other time or on such other date as is agreed to in writing by the Buyer and the Seller by no later than April 6, 2026. |

---

The date of the Closing, which shall not be later than April 6, 2026, is referred to herein as the "**Closing Date**" and the Closing shall be deemed to occur as of the close of business on the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.8 Delivery by Seller

On the Closing Date, the Seller shall deliver to the Buyer, each of which shall be in full force and effect, unless waived by Buyer:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.8.1** Duly executed Minutes of the meeting of the Seller's Board of Directors, approving the sale of the
Purchased Asset, the entry into this Asset Purchase Agreement and all other elements of the transactions contemplated under this Agreement
and the agreements and documents ancillary thereto (the "**Ancillary Agreements** "), such resolution substantially in the
form attached hereto as  **<u>Annex 2.8.1.</u>** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.8.2** Dully executed consents by the pertinent party to the extent required in order to properly assign the
Transferred Contracts to Buyer (excluding Transferred Leasehold which is the responsibility of Buyer to obtain necessary landlord consent
and release of Seller), including, without limitation, the consent of Yissum ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.8.3** Notices of Assignment dully executed by Seller informing the counterparties of the assignment of the Transferred
Contracts to Buyer, subject to Section ‎7.3);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.8.4** Fully executed documents required for the assignment of the Transferred IP from Seller to Buyer including,
without limitation, any and all patent and trademark assignment documents (from the US PTO or otherwise), to the extent applicable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.8.5** Written confirmation/approval from the Israel Innovation Authority (IIA), expressly approving the transfer
and assumption by Buyer of all rights and obligations under IIA R&D Programs relating to the Business (namely programs number 53261,
55987 and 90013) (the "**IIA Approval** ").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.9 Delivery by Buyer

On the Closing Date, Buyer shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.9.1** Deliver executed form of assumption of rights and obligations form pertaining to Seller's outstanding
IIA obligations concerning the Business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.9.2** Wire - transfer the Closing Payment to Seller.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.10 Retention

Prior to (and not later than) the Closing, Buyer shall be free, in its sole discretion, to negotiate potential employment terms with any Key Personnel following their termination by Seller. Seller makes no representation and undertakes no obligation with respect to the acceptance of any such engagement by the Key Personnel. For the avoidance of doubt, Seller shall have no obligation to ensure that any such individual accepts employment with Buyer and Seller shall not bear any responsibility or liability of any kind in the event any Key Personnel decline or fail to accept Buyer's offer of employment, regardless of the reason.

3 OBLIGATIONS BETWEEN SIGNING AND closing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 Third- Party Consents

**Notwithstanding anything to the contrary in this Agreement, the Parties acknowledge that some of the consents required under Section ‎2.8.5 might not be obtained prior to signing of this Agreement anticipated on March 31, 2026, including the consent required from the Landlord in connection with the Transferred Leasehold, the consent of Yissum in connection with the Yissum Agreement and consent of the IIA to the transfer of the IIA Liabilities. The Parties shall cooperate in good faith, and shall use commercial reasonable efforts to obtain all such consents, approvals and confirmations as promptly as practicable prior to Closing Date and subject to Closing (the "Post – Signing Undertaking Period"). Following the signing of the Agreement, Seller and Buyer shall use commercially reasonable efforts, and shall cooperate with each other, to obtain any such required consent or waiver, or any release, substitution or amendment required to assign all Transferred Contracts and the IIA Approval.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 Transfer of Computers

**During the Post - Signing Undertaking Period, Seller and Buyer shall cooperate in good faith and use commercially reasonable efforts to transfer to Buyer as of the Closing Date and subject to Closing, all computers, and related equipment, together with any associated access credentials, that are included in the Purchased Assets, in each case excluding the servers (collectively, the "Transferred IT Assets"). Such transfer shall be effected as promptly as practicable and in any event within the Post - Signing Undertaking Period, subject to Closing and subject to applicable Law and any required third-party consents.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3 Termination of Employment of Key Personnel

During the Post - Signing Undertaking Period, Seller shall take all internal actions required to terminate the employment of the Key Personnel as of and subject to the Closing in accordance with applicable Law and the applicable employment agreements and policies. For the avoidance of doubt and without derogating from the foregoing, Buyer shall have no responsibility or liability for any obligation of Seller arising from or relating to the termination of employment of the Key Personnel through the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4 Transfer of Third - Party Licenses

**During the Post - Signing Undertaking Period, Seller and Buyer shall cooperate in good faith and use commercially reasonable efforts to take such actions as may be necessary or advisable to efficiently transfer, assign or novate to Buyer (solely to the extent included in the Purchased Assets), or assist Buyer to procure by Buyer replacement licenses for Buyer, to the extent permitted by the applicable terms and conditions, all third party licenses, subscriptions and rights (including any maintenance and support rights) used in or necessary for the operation of the Business and the Purchased Assets following and subject to Closing in the same manner operated by Seller prior to Closing (collectively, the "Third Party Licenses Such cooperation shall include (as applicable) and at Buyer's express request contacting the relevant licensors, executing documentation reasonably required by such licensors, and providing reasonable information and assistance requested by the applicable licensor to effect such transfer. Buyer shall bear all fees and charges imposed by third parties in connection with the transfer, assignment, novation or replacement of the Third - Party Licenses, and, unless otherwise agreed in writing, any such Third - Party Licenses that are not transferable shall be addressed in accordance with Section 6.3 (Temporary Transition Arrangements), to the extent permitted under the terms of the applicable licenses.** 

---

| | |
|:---|:---|
| **4** | **Closing Without Satisfaction of Certain Conditions; Post-Closing Undertakings.** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.1** The Parties acknowledge and agree that, notwithstanding anything to the contrary in this Agreement, if
the Closing has not occurred on or prior to April 6, 2026 (the "**Target Date**") due to the absence of any third party
or Governmental Authority consents, approvals, confirmations or waivers relating to a Transferred Contract (including the Transferred
Leasehold) and/or the IIA Approval (each, an "**Unfulfilled Condition** "), the Closing shall be automatically consummated
on such Target Date, irrespective of any such missing consents. Such consummation of the Closing shall constitute an irrevocable waiver
by Buyer of any such Unfulfilled Condition, and Buyer shall assume all risks, liabilities and obligations arising from or relating to
the absence of such consents, approvals, confirmations or waivers, and shall acquire the business on an "as is" basis, including
with respect to any matters arising therefrom. The Closing shall be deemed completed and effective in all respects as of the Target Date,
notwithstanding the existence of any Unfulfilled Condition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 Without limiting the foregoing, the Parties shall perform the post-closing
undertakings and obligations expressly set forth in this Agreement (including those under Section 3 if not fulfilled on the Closing) following
the Closing. Buyer shall be solely responsible, at its sole cost and expense, for obtaining (and shall use commercially reasonable efforts
to obtain) any and all consents, approvals, confirmations and waivers from third parties and/or Governmental Authorities required in connection
with the transfer, assignment, novation, registration, perfection, use or operation of the Purchased Assets or the Business after the
Closing, and Buyer shall bear and be solely responsible for any payments, fees, charges, penalties, costs and expenses imposed in connection
therewith. To the extent that any Transferred Contracts cannot be transferred to Buyer as of the Target Date and/or and/or IIA Approval
cannot be obtained by the Target Date, Buyer and Seller shall use commercially reasonable efforts to enter into such arrangements (such
as subleasing, sublicensing or subcontracting) to provide to the parties the economic and, to the extent permitted under applicable Law,
operational equivalent of the transfer of such Transferred Contract to Buyer as of the Closing. Buyer shall, as agent or subcontractor
for Seller, pay, perform and discharge fully the liabilities and obligations of Seller thereunder from and after the Closing. To the extent
permitted under applicable Law, Seller shall, at Buyer's expense, hold in trust for and pay to Buyer promptly upon receipt thereof, all
income, proceeds and other monies received by Seller from and after the Closing, to the extent related to such Transferred Contract in
connection with the arrangements under this Section ‎ 4.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 During the period in which Seller is performing any post-closing undertakings
or obligations expressly required of Seller under this Agreement, including under this Section 4, (the " Post-Closing Performance
Period "), Buyer (on behalf of itself and its Affiliates) irrevocably waives, releases and covenants
not to sue Seller or any of its Affiliates, and shall not assert any claim, demand, action or proceeding against Seller or any of its
Affiliates, whether in contract, tort or otherwise, arising out of or relating to any Unfulfilled Condition and/or Seller's performance
(or non-performance) of such post-closing undertakings or obligations, except to the extent resulting from Seller's fraud or willful
misconduct.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4 For the avoidance of doubt, from and after the Closing, including the
Post-Closing Performance Period, subject to the terms and conditions of this Agreement, Buyer shall assume and be solely responsible for
all liabilities, obligations, claims, losses, damages and expenses arising out of or relating to the Purchased Assets and/or the Business
(including any liabilities associated with obtaining any required consents, approvals, confirmations or waivers), except solely to the
extent expressly retained by Seller as an Excluded Liability under this Agreement.

5 Consideration

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1** **The Purchase Price.** In return for the Purchased Assets, Buyer shall
 pay the Seller the amount of up to $12,500,000 plus VAT, to the extent applicable (the "**Total Consideration** "), in the following manner:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1.1** <u>Closing Payment</u>. At Closing, Buyer shall pay to Seller an amount equal to US$2,000,000 plus
VAT, to the extent applicable, in immediately available funds by wire transfer (the "**Closing Payment** "); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1.2** <u>Deferred Consideration</u>. In addition to the Closing Payment, Buyer shall pay to Seller, as additional
purchase price for the Purchased Assets, such amount that reflects (A) 50% of the aggregate AME Net Cash Proceeds during the Deferred
Consideration Period, capped at USD 4,000,000 plus VAT, to the extent applicable, and (B) 50% of the aggregate Fabrica Net Cash Proceeds
during the Deferred Consideration Period, capped at USD6,500,000 plus VAT, to the extent applicable (collectively, the "**Deferred Consideration"** and, collectively with the Closing Payment, the **"Purchase Price").** Notwithstanding anything
to the contrary herein, the aggregate Deferred Consideration payable to Seller shall be reduced, on a dollar for dollar basis, by an amount
equal to USD 111,762, representing the Customer Advances, as set forth in  **<u>Annex 1.1.11</u>** . Such reduction shall be applied
against the Deferred Consideration otherwise payable hereunder, and no portion of such amount shall be payable to Seller.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1.3** <u>Quarterly Calculations and Payments.</u> Buyer shall calculate AME Net Cash Proceeds and Fabrica Net
Cash Proceeds on a quarterly basis. Within thirty (30) days following the end of each full three-month period after the Closing Date,
Buyer shall deliver an Earn-Out Statement to Seller and shall pay the resulting Deferred Consideration (if any) for such quarter, together
with the backup described in Section ‎5.1.5 and  **<u>Annex 5.1.3</u>** . The Earn-Out Statements and all calculations of Deferred
Consideration shall reflect the deduction of the Customer Advances amount as set forth in Section 5.1.2 and shall be audited and approved
by Buyer's independent public accountant that also reviewes and audits the financial statements of Buyer that are being submitted
to the SEC and the public.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1.4** <u>Final True-Up.</u> Within thirty (30) following the end of the Deferred Consideration Period, Buyer
shall deliver a final Earn-Out Statement setting forth the aggregate AME Net Cash Proceeds and Fabrica Net Cash Proceeds for the Deferred
Consideration Period and the total Deferred Consideration payable (subject to the cap) ("Deferred Consideration Period Statement"),
and Buyer shall pay any unpaid remaining Deferred Consideration, together with applicable VAT, to the extent applicable, within such 30-day
period. The Earn-Out Statements and all calculations of Deferred Consideration shall reflect the deduction of the Customer Advances amount
as set forth in Section 5.1.2. Within thirty (30) days following the end of the six (6) month period after the end of the Deferred Consideration
Period, Buyer shall deliver to Seller an additional Earn-Out Statement (the "Post-Period Collections Statement") setting forth
(A) the aggregate AME Net Cash Proceeds and Fabrica Net Cash Proceeds actually collected during such six (6) month period that are eligible
to be included pursuant to the definitions of AME Net Cash Proceeds and Fabrica Net Cash Proceeds, and (B) the resulting additional Deferred
Consideration payable in respect thereof. Buyer shall pay any additional amount shown as payable to Seller in the Post-Period Collections
Statement, together with applicable VAT, within such thirty (30) day period. The Earn-Out Statements and all calculations of Deferred
Consideration shall reflect the deduction of the Customer Advances amount as set forth in Section 5.1.2

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1.5** <u>Records and Review.</u> Buyer shall maintain reasonably detailed books and records supporting
the Earn-Out Statements for at least eighteen (18) months following the end of the Deferred Consideration Period. Seller may, at its expense,
engage an independent accounting firm to review such records for the sole purpose of verifying the Earn-Out Statements, during normal
business hours and upon at least two (2) Business Days' prior written notice, subject to reasonable confidentiality undertakings.
Buyer shall provide Seller and its accounting firm with reasonable access to the books, records, work papers, invoices, supporting schedules
and other backup information reasonably necessary to verify the Earn-Out Statements, . Any disputes shall be resolved pursuant to Section
‎5.1.6.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1.6** <u>Earn-Out Dispute Resolution.</u> If Seller disputes an Earn-Out Statement, Seller shall notify Buyer
in writing within twenty (20) Business Days after receipt, specifying in reasonable detail the disputed items. The Parties shall attempt
in good faith to resolve the dispute within fifteen (15) Business Days. If not resolved, the dispute shall be submitted to an independent
"big 4" accounting firm, which is not affiliated with any of the Parties and has not provided any service to any of the Parties
during the preceding 3 months, as mutually agreed by the Parties acting as an expert and not as an arbitrator. The expert's determination
shall be final and binding absent manifest error. Fees shall be allocated as determined by the expert (or otherwise 50/50 if not specified).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1.7** <u>Withholding.</u> All payments shall be subject to withholding as required by applicable Law, subject
to Seller providing any valid withholding certificates or tax rulings. Buyer shall cooperate reasonably with Seller to minimize any withholding
to the extent permitted by law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1.8** <u>VAT</u>. All amounts payable under this Agreement shall be increased by any applicable VAT to the extent
required by law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1.9** <u>Commercially Reasonable Operation</u>. Buyer shall operate the transferred Business and the Purchased
Assets in a commercially reasonable manner and shall not take any action or omit to take any action with the primary purpose or reasonably
foreseeable effect of reducing Deferred Consideration or AME Net Cash Proceeds or Fabrica Net Cash Proceeds.

6 CONFIDENTIAL INFORMATION

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 Disclosure

For purposes of this Agreement, "**Confidential Information**" means any proprietary information, technical data, trade secrets or know-how, including, but not limited to, research, business plans or models, product plans, products, services, computer software and code, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances or other business information disclosed by either Party to the other Party, whether directly or indirectly, in writing, orally to Seller or by drawings or inspection of parts or equipment or owned by Buyer even though not delivered by the Buyer to Seller. It is understood that all Confidential Information of a Party shall remain the sole property of such Party and the receiving Party shall not have any interest therein. Upon the disclosing Party's request, the receiving Party shall promptly return to the disclosing Party all such tangible Confidential Information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 Exclusions

Notwithstanding the provisions of Subsection ‎6.1, Confidential Information shall exclude information that the receiving Party can demonstrate: (i) was independently developed by the receiving Party without any use of the disclosing Party's Confidential Information or by the receiving Party's employees or other agents (or independent contractors hired by the receiving Party) who have not been exposed to the disclosing Party's Confidential Information; (ii) becomes known to the receiving Party, without restriction, from a source other than the disclosing Party (or the disclosing Party Confidential Information) that had a right to disclose it without breach of this Agreement; or (iii) was in the public domain at the time it was disclosed or enters the public domain through no act or omission of the receiving Party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 Transferred Software

Notwithstanding anything in Subsection ‎6.1 and Subsection ‎6.2, prior to the Closing, the Transferred Software (other than Transferred Third Party Software) and any other non public information regarding the Transferred Intellectual Property Rights shall be deemed Confidential Information of Seller, and as of and subject to the Closing, the Transferred Software (other than Transferred Third Party Software) and any other non-public information regarding the Transferred Intellectual Property Rights shall be deemed Confidential Information of Buyer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4 Confidentiality Obligations

Each Party shall treat as confidential and not disclose to any third party any of the other Party's Confidential Information and shall not use such Confidential Information for its or their own benefit. Without limiting the foregoing, each Party shall use at least the same degree of care which they use to prevent the disclosure of their own confidential information of like importance, but in no event with less than reasonable care, to prevent the disclosure of the other Party's Confidential Information. Each Party further agrees to take all reasonable precautions to prevent any unauthorized disclosure or use of any Confidential Information of the other Party. Each Party shall, upon written request of the other Party, destroy or deliver to such Party all such Confidential Information in its possession, and shall provide written confirmation that all such materials have been delivered or destroyed, provided, however, that each Party shall be entitled to keep a copy of the Confidential Information solely for archival and compliance purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5 Transaction Public Announcement

The Parties agree that the public announcements concerning the transaction contemplated under this Agreement shall be substantially in the forms and substance attached hereto as **<u>Annex ‎6.5</u>** (the "**Transaction Public Announcements**"). The Parties shall be entitled to issue additional public announcement concerning the transaction contemplated under this Agreement only following the public release of the Transaction Public Announcements.

7 FURTHER CONVEYANCES AND ASSUMPTIONS; CONSENT OF THIRD PARTIES

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.1** Subject to the Closing, and during the Post-Closing Assistance Period only, the Seller agrees to give
the Buyer the right to, on behalf of and for the benefit of the Buyer and at Buyer's cost and expense: (i) to demand and receive
from time to time any and all the Purchased Assets and to make endorsements and give receipts and releases for and with respect to the
same and any part thereof; and (ii) to institute, prosecute and settle any and all actions or proceedings that Buyer may deem proper in
order to collect, assert or enforce any claim, right or title of any kind in or to the Purchased Assets; (iii) to defend or settle any
or all actions or proceedings with respect to any of the Purchased Assets, (iv) to do all such acts and things in relation thereto as
Buyer shall deem necessary or desirable for the operation of the Business. Without limiting the foregoing, in the event that the Seller
receives, at any time after the Closing, any payments related to the Business (including without limitation from any third party for payment
under any Transferred Contract), solely to the extent such payment relates to post-Closing periods and not to services already performed
by Seller prior to Closing, the Seller shall promptly transfer such payment to Buyer as designated by Buyer. Any amounts received by Seller
that relate to periods prior to Closing, other than in respect of the Accounts Receivables or that relate to services actually performed
by Seller prior to Closing, shall belong exclusively to Seller.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.2** Without derogating from the foregoing, from time to time following the Closing, during the Post-Closing
Assistance Period only and without additional consideration to the Seller, the Seller and Buyer shall, and shall cause their respective
Affiliates to, execute, acknowledge and deliver in a reasonably prompt manner, all such further conveyances, notices, assumptions, releases
and such other instruments, and shall take such further actions, in each case, as may be commercially reasonably necessary or appropriate
to assure fully to Buyer and their respective successors or assignees, all of the properties, rights, titles, interests, remedies, powers
and privileges intended to be conveyed to Buyer under this Agreement including with respect to the Purchased Assets and to assure to the
Seller and its Affiliates, successors and assignees, the assumption of the Assumed Liabilities, and to otherwise make effective the transactions
contemplated hereby and thereby provided that Buyer shall bear all expenses in connection with the foregoing and that none of the foregoing
shall not require Seller to incur any liability, provide transition services, or undertake any substantive business activity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.3** Notwithstanding anything to the contrary in this Agreement, to the extent that the sale, assignment, transfer,
conveyance, or delivery to Buyer of any Purchased Asset requires any authorization, approval, consent, or waiver of any Governmental Body
or third party, and any such authorization, approval, consent, or waiver has not been obtained prior to the Closing Date (or the Closing
otherwise occurs notwithstanding the non-satisfaction of such requirement), then such asset shall be identified in  **<u>Annex ‎7.3</u>** and designated for a temporary transition arrangement. The Parties shall enter into such transition arrangement, in a form mutually agreed
upon, for a period of up to 6 months pursuant to which, as between Seller and Buyer, Buyer shall assume all obligations and be entitled
to all rights with respect to such Purchased Asset (including under any Transferred Contract). The Parties shall cooperate in good faith
following Closing to implement such arrangement. Seller shall not be required to provide any substantive post-Closing performance, and
shall have no liability with respect to any such asset or arrangement (and likewise, shall not be entitled to any benefit or payment in
respect thereof), except in case of a liability caused due to Seller's gross negligence or willful misconduct in performing expressly
agreed transition services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.4** Except as expressly set forth in  **<u>Annex 7.4</u>** , no rights under any nondisclosure, non-competition,
non-solicitation or assignment agreements to which Seller is a party shall be deemed assigned to Buyer. To the extent any such agreement
is expressly assigned or made available for Buyer's benefit, Buyer shall assume all obligations thereunder and shall indemnify and
hold Seller harmless from and against any and all liabilities arising out of Buyer's use of or reliance upon such agreement following
Closing. The confidentiality provisions of this Agreement shall supersede and replace any prior confidentiality arrangements between the
Parties with respect to the transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.5** Notwithstanding anything to the contrary in this Agreement, it is hereby clarified that, with respect
to any employees of the Seller who will not be retained by Buyer following the Closing and whose employment with the Seller has been terminated
prior to the Closing or following the Closing, the Seller shall has no obligation and shall bear no responsibility to enforce, monitor,
support, or take any action whatsoever with respect to any nondisclosure, non competition, non solicitation, invention assignment or similar
undertakings of such former employees. The Seller shall not be required to initiate any legal proceedings or take any enforcement action
against such former employees unless: (i) the Buyer provides a written request identifying the alleged breach, (ii) the Buyer fully funds
in advance all costs and expenses incurred in connection therewith and provides adequate security acceptable to the Seller, and (iii)
such action does not impose any liability, exposure, cost, or obligation on the Seller.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.6** Without derogating from Seller's obligations under Section 7 (the Post-Closing Assistance Period),
during a period of 60 days following the Effective Date, Seller shall, upon Buyer's reasonable written request and at Buyer's
expense, reasonably cooperate with Buyer and its Representatives and provide such information, data and documents in Seller's possession
or control to the extent relating to the Purchased Assets and the Business as is reasonably necessary for purposes of auditing and verifying
matters related to the Purchased Assets and the Business; provided that (i) such cooperation and provision of information shall be subject
to reasonable confidentiality and data security requirements and applicable Law, (ii) Buyer shall not unreasonably interfere with Seller's
operations, and (iii) Seller shall not be required to create, reconstruct, or supplement any information, data, documents, books or records
not maintained by Seller in the ordinary course of business. For the avoidance of doubt, Seller shall not be required to provide Buyer
or its Representatives access to Seller's books and records <u>.</u> 

8 REPRESENTATIONS AND WARRANTIES OF BUYER

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.1** Buyer represents and warrants to Seller, as of the Effective Date and the Closing Date, as though made
as of the Closing Date, as follows: it is a corporation duly organized, validly existing and in good standing under the laws of its jurisdiction
of incorporation and has all requisite corporate power and authority to own, lease and operate its business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.2** It has the full right, power and authority to enter into this Agreement and any Ancillary Agreements to
which it is a party and fully perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby
and thereby. The execution, delivery and its performance of this Agreement and each Ancillary Agreement to which it is a party have been
duly authorized by all necessary corporate actions on its behalf.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.3** The execution, delivery and performance of this Agreement and any Ancillary Agreement to which it is a
party do not and will not (i) contravene, conflict with, or result in a violation of or breach of any provision of its organizational
documents, (ii) contravene, conflict with, or result in any violation or breach of any provision of any judgment, injunction, order or
decree of Governmental Body by which Buyer is bound, (iii) contravene, conflict with, or result in any violation or breach of any provision
of any law applicable to it.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.4** There are no actions, suits, arbitrations, mediations, proceedings or claims pending or, to the best of
its knowledge, threatened against it that seek to restrain or enjoin the consummation of the transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.5** <u>As-Is Purchase; No Reliance</u>. Buyer acknowledges and agrees that, except for the Fundamental Representations
expressly set forth in Sections ‎9.2, ‎9.3 and ‎9.5 (the "**Fundamental Representations** "), the Purchased
Assets are being sold, assigned, transferred and conveyed on an "as is, where is" basis, with all faults, and without any
representation or warranty of any kind, express or implied, at law or in equity, including any implied warranties of merchantability,
fitness for a particular purpose, title (other than as expressly set forth in the Fundamental Representations), non - infringement, functionality,
condition, compliance with applicable law, collectability, enforceability or sufficiency for the operation of the AME Business. Without
limiting the generality of the foregoing, Buyer acknowledges and agrees that it has conducted, to its satisfaction, an independent investigation
of the Purchased Assets and the AME Business, and that it is not relying, and has not relied, on any representation or warranty, express
or implied, of Seller or any of its affiliates or representatives, other than the Fundamental Representations expressly set forth in this
Agreement.

9 REPRESENTATIONS AND WARRANTIES OF SELLER

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.1** Except as specifically disclosed in the disclosure schedule attached hereto (the "**Disclosure Schedule**") (referencing the appropriate section and paragraph numbers), Seller represents and warrants to Buyer, as of the Effective
Date and the Closing Date, as though made as of the Closing Date, as follows (the "**Fundamental Representations** "):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.2** **Validity and Good Standing**. Seller is a company duly incorporated and validly existing under the
laws of the State of Israel. Seller has the corporate power and authority necessary to enter into this Agreement and the Ancillary Agreements
to which it is or will be a party and to consummate the transactions contemplated hereby and thereby. The execution, delivery and performance
by the Seller of this Agreement and of each such other Ancillary Agreement have been duly authorized by all necessary action on the part
of Seller and its board of directors. This Agreement and any Ancillary Agreements that have been duly executed and delivered by Seller
constitute the valid and binding obligations of Seller enforceable against Seller in accordance with their terms, subject only to the
effect, if any, of (i) applicable bankruptcy and other similar laws affecting the rights of creditors generally and (ii) rules of law
governing specific performance, injunctive relief and other equitable remedies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.3** **Authority.** The execution, delivery and performance by Seller of this Agreement and any Ancillary
Agreement to which it is a party do not and will not (i) contravene or violate its organizational documents, (ii) contravene or violate
any applicable law binding upon Seller, or (iii) contravene or violate any judgment, injunction, order or decree binding upon Seller,
except in each case as would not prevent Seller from consummating the transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.4** **No Power of Attorney.** No Person has on the Closing Date a valid power of attorney granted by the
Seller in respect of any Purchased Assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.5** **Ownership.** Seller is the exclusive owner of all right, title and interest to and in the Purchased
Assets; provided that with respect to any Third-Party Software, the Seller has a valid license to use such Third-Party Software.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.5.1** **The Purchased Assets are free and clear of any Encumbrances (other than the IIA Liabilities).** The
Purchased Assets include all of the Software and Intellectual Property Rights owned and transferable by Seller that relate to the Business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.5.2** To the Seller's best knowledge, the Transferred IP and Third - Party Software, have not and do not
infringe any third party's Intellectual Property Rights, including, but not limited to patents, Trademarks, trade secrets, or copyrights
of any third party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.5.3**  **<u>Schedule ‎9.9.3</u>** of the Disclosure Schedule lists all registrations and registration
applications pendent with respect to the Transferred Intellectual Property Rights (collectively, "**Transferred Registrations** ").
With respect to such Transferred Registrations, to the best knowledge of the Seller, all necessary registration, maintenance, and renewal
fees have been paid as listed in  **<u>Schedule ‎9.9.3</u>** of the Disclosure Schedule.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.5.4**  **<u>Schedule ‎9.9.4</u>** of the Disclosure Schedule provides a complete, accurate list of
 all Third-Party Software included in the Transferred Software.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.5.5** Except as set forth in  **<u>Schedule ‎9.9.5</u>** of the Disclosure Schedule, the Purchased Assets
constitute all assets and/or rights of Company used in the operation of the Business as conducted as of the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.6** **Litigation.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.6.1** There has not been any and there
is no action, suit, claim, proceeding or investigation of any nature pending or threatened against Seller arising out of the ownership
or use of the Purchased Assets in the operation of the Business as conducted as of the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.7** **Confidentiality.** Seller has taken all reasonable steps that are required to protect Seller's
rights in Confidential Information and Trade Secrets within the Transferred Software.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.8** **Public Agencies.** Except as set forth in  **<u>Schedule 9.12</u>** of the
Disclosure Schedule, no funding, facilities or personnel of any Governmental Body, university, college, other educational institution
or research center or funding from third parties was used directly or indirectly in the development of the Purchased Assets in whole or
in part.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.9** **Governmental Grants** 

**9.10** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.10.1** Except as set forth in  **<u>Schedule 9.13</u>** , none of the Transferred Intellectual
Property Rights were developed by or for or on behalf of, or using grants or any other subsidies of, any governmental entity or any university,
and no government funding, facilities, faculty or students of a university, college, other educational institution or research center
or funding from third parties was used in the development of the Seller's Intellectual Property ()"**Grants** ").  **<u>Schedule 9.13</u>** sets forth: (a) the aggregate amount of each Grant; (b) the aggregate outstanding obligations of Seller under each Grant with
respect to royalties or other payments; and (c) the outstanding amounts to be paid to Seller under the Grants by the governmental entity,
if any. Seller is in material compliance with the terms and conditions of each Grant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.10.2** Save for IIA approval, no consent or any other approval is required from the foregoing entities in order
to give force to the transactions contemplated herein and thereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.10.3** Seller has made all payments due until Closing, and has fully complied with all material requirements
under the Yissum Agreement until Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.11** **Key Personnel.** Seller shall use best efforts terminate the employment of all Key Personnel prior
to the Closing Date in accordance with applicable law. In any event, Seller shall be solely responsible for all liabilities and obligations
whatsoever, including but not limited to, statutory severance payments, accrued wages, accrued vacation, and other benefits, arising from
or in connection with the termination of employment of such Key Personnel up to the Closing Date. Buyer intends to offer employment to
such Key Personnel effective as of the Closing Date and will assume all liabilities and obligations related to their employment from and
after the Closing Date. Buyer shall be solely responsible for any employment offers, employment arrangements and all liabilities arising
therefrom from and after Closing. Seller makes no representation or warranty or undertaking regarding any employee, rehiring, transition,
retention or employment matters other than that Seller shall be responsible for termination obligations accruing through Closing under
applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.12** **Inventory Condition. <u>Scheule 9.16</u>** lists the Inventory. The Inventory
has been stored, handled, packaged and maintained in a manner consistent with past practice and applicable Law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.13** **Transferred Contracts. <u>Schedule 9.17</u>** sets forth a true, correct and
complete list of all Transferred Contracts (including the Transferred Customer Contracts and the Transferred Leasehold).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.14**  **<u>Schedule 9.17</u>** of the Disclosure Schedule identifies any (i) Transferred
Contract which is a Governmental Contract, (ii) any Transferred Contract which is made in connection with any tender, (iii) any terms
and conditions and/or SLAs provided to clients of Seller which are parties to a Transferred Contract.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.15** **Limited Representations; As-Is Acquisition.** Notwithstanding anything to the contrary herein, Seller
makes only the representations expressly set forth in this Section ‎9, and no other representation or warranty, express or implied,
is made by Seller with respect to the Purchased Assets, the AME Business or otherwise. Without limiting the generality of the foregoing,
Seller disclaims any and all other representations and warranties, including any implied warranties of merchantability, fitness for a
particular purpose, title (other than as expressly set forth in the Fundamental Representations) and non-infringement. Buyer acknowledges
and agrees that the Purchased Assets are being acquired on an "as is, where is" basis, with all faults.

10 SURVIVAL OF REPRESENTATIONS AND WARRANTIES; INDEMNIFICATION

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.1** **Survival of Representations, Warranties, Covenants and Agreements.** 

The Fundamental Representations shall survive the Closing Date for a period of two (2) months following the Closing Date; provided, however, that claims based upon an intentionally misleading or deceptive representation, a willful act or omission intended to intentionally breach any covenants, or fraud (collectively, "**Fraud Matters**") shall survive as provided by applicable law. All other representations and warranties in this Agreement or in any Ancillary Agreement are hereby disclaimed and shall not survive Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.2** **Limits on Liability.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.2.1.1 Except
 in the case of any Fraud Matters set forth in this Agreement Seller shall not be obligated
 to Buyer whether under indemnity, contract, tort or otherwise and shall have no obligation
 to indemnify Buyer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.3** Neither Party shall be liable for any special, indirect, incidental, punitive or consequential loss, such
as loss of business opportunities or loss of goodwill, whether in respect of any misrepresentation, breach of contract (other than Fraud
Matters) tort, statutory duty or otherwise, which arises out of or in connection with this Agreement or its subject matter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.4** In all cases, except Fraud Matters, and without derogating from other limitations of liability specified
herein, the Seller's aggregate liability under this Agreement, the Ancillary Agreements, and in connection with all transactions
contemplated hereunder and thereunder, whether under this Agreement, tort or otherwise, shall not exceed the amount of the value of the
Purchase Price.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.5** If the transaction is not consummated due to failure to meet certain of the Closing conditions set forth
herein, no liability shall be imposed on either party hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.6** Notwithstanding anything to the contrary set forth in this Agreement, nothing in this Agreement shall
limit the rights of any Party hereto to apply for equitable remedies to enforce the other Parties' obligations hereunder.

---

| | |
|:---|:---|
| 11 | GENERAL |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.1** **Amendments.** This Agreement may not be amended, modified, altered or supplemented other than by
means of a written instrument duly executed and delivered on behalf of both Seller and Buyer. Each subsequent Exhibit mutually agreed
to and signed by the Parties shall be governed by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.2** **Costs and Expenses.** Except as expressly provided herein, each Party shall be solely responsible
for its own costs and expenses (including its attorneys' fees and accountants' fees): (i) incurred in negotiating and consummating
the transactions contemplated hereby, and (ii) for maintaining and perfecting the rights granted to such Party hereunder, including costs
for recordation of documents, registration of rights and payment of government fees incurred after the Effective Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.3** **No Agency.** Each Party shall in all matters relating to this Agreement act as an independent contractor.
None of the Parties shall have authority, nor shall either Party represent that it has any authority, to assume or create any obligation,
express or implied, on behalf of the others, or to represent the other Parties as agent or employee or in any other capacity. Neither
execution nor performance of this Agreement shall be construed to have established any agency, joint venture or partnership.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.4** **Notices.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.4.1** Any notice or other communication required or permitted to be delivered to any Party under this Agreement
must be in writing and shall be deemed properly delivered, given and received when delivered (by hand, by registered mail, by courier
or express delivery service or by facsimile) to the address or facsimile telephone number set forth beneath the name of such Party below
(or to such other address or facsimile telephone number as such Party may have specified in a written notice given to the other Parties):

If to Seller:_

Nano Dimension Technologies Ltd.

60 Tower Road, Waltham,

Massachusetts, 02451, USA

Attn: David Stehlin, CEO

Email: david.stehlin@markforged.com

With a copy to:

(which shall not constitute notice):

Pearl Cohen Zedek Latzer Baratz

Azrieli Sarona Tower, 53rd Floor

121 Menachem Begin Road

Tel-Aviv 6701203, Israel

Attn: Adv. Zeev Pearl

Email: ZPearl@pearlcohen.com

If to Buyer:

Inspira Technologies Oxy B.H.N. Ltd.

2 Ha'Tidhar St.,

Ra'anana, 4366504, Israel

Attn: Dagi Ben-Noon, CEO

Email: dagi@inspirao2.com

With a copy to:

(which shall not constitute notice):

Sullivan & Worcester Tel-Aviv

28 Ha'arbaa st., Tel-Aviv, Israel

Attention: Tamir Chagal, Adv.

Email: tchagal@sullivanlaw.co.il

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.4.2** Any notice delivered by hand or by courier to the Party to whom it is addressed as provided above shall
be deemed to have been given and received on the day it is so delivered at such address. If such day is not a Business Day, or if the
notice is received after 4:00 p.m. (addressee's local time), then the notice shall be deemed to have been given and received on
the next Business Day. Any notice transmitted by facsimile shall be deemed to have been given and received on the day in which transmission
is confirmed. If such day is not a Business Day or if the facsimile transmission is received after 4:00 p.m. (addressee's local
time), then the notice shall be deemed to have been given and received on the first Business Day after its transmission. Any notice delivered
by electronic mail to the applicable email address set forth above shall be deemed to have been duly given and received at the time of
transmission, provided that the sender does not receive an automated error message or other notification of non-delivery, and provided
further that if such transmission occurs on a day that is not a Business Day or after 4:00 p.m. (addressee's local time), such notice
shall be deemed to have been given and received on the next succeeding Business Day.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.5** **Governing Law; Jurisdiction.** This Agreement shall be governed by and construed in accordance with
the laws of the State of Israel excluding that body of law pertaining to conflict of law. The Parties agree to submit to the exclusive
jurisdiction of the State of Israel and the courts of Tel Aviv-Jaffa with respect to the breach or interpretation of this Agreement or
the enforcement of any and all rights, duties, liabilities, obligations, powers, and other relations between the parties arising under
this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.6** **Waiver** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.6.1** No failure on the part of a Party to exercise any power, right, privilege or remedy under this Agreement,
and no delay on the part of any Party in exercising any power, right, privilege or remedy under this Agreement, will operate as a waiver
of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy will preclude
any other or further exercise thereof or of any other power, right, privilege or remedy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.6.2** No Party shall be deemed to have waived any claim arising from this Agreement, or any power, right, privilege
or remedy under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written
instrument duly executed and delivered on behalf of such Party; and any such waiver will not be applicable or have any effect except in
the specific instance in which it is given.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.7** **Assignment.** Neither Party shall have the right to assign or transfer this Agreement, or any of
its rights hereunder (provided that, Buyer may assign, transfer and take all actions it deems fit with respect to the Transferred Assets
following Closing), without the prior written permission of the other Party, which may be granted or withheld at its sole discretion.
Any assignment in violation of this Subsection ‎11.7 is null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.8** **Severability.** If, for any reason, a court of competent jurisdiction finds any provision of this
Agreement, or portion thereof, to be invalid or unenforceable, such provision of this Agreement will be enforced to the maximum extent
permissible so as to effect the intent of the Parties, and the remainder of this Agreement will continue in full force and effect. The
Parties agree to negotiate in good faith an enforceable substitute provision for any unenforceable provision that most nearly achieves
the intent and economic effect of the unenforceable provision. Notwithstanding the foregoing, if a court of competent jurisdiction determines
that any restriction on any license granted herein is invalid or unenforceable, then the license grants to which such restriction relates
shall terminate automatically.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.9** **Entire Agreement.** This Agreement (including the Exhibits and Annexes hereto) sets forth the entire
understanding of the Parties hereto relating to the subject matter hereof and supersedes all prior agreements and understandings between
or among the Parties hereto relating to the subject matter hereof. Except for the representations and warranties explicitly set forth
in this Agreement, no Party makes any other representation or warranty, whether express or implied, to any other Party with respect to
the Purchased Assets or otherwise in connection with the transactions contemplated by this Agreement. Upon Closing, the debenture notes
issued in respect of the Advance Payments, shall be deemed fully paid and satisfied.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.10** **No Third - Party Beneficiaries.** The terms and provisions of this Agreement are intended solely
for the benefit of each Party and their respective permitted successors and permitted assigns, and the Parties do not intend to confer
third party beneficiary rights upon any other Person, other than the Indemnified Parties which will be deemed third party beneficiaries
for the purposes of Section ‎10.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.11** **Counterparts.** This Agreement may be executed in counterparts, which, when taken together, shall
constitute one agreement.

 

*[Remainder of Page Intentionally Left Blank]*

**IN WITNESS WHEREOF**, the parties hereto have caused this Agreement to be duly executed by this respective authorized officer as of the date first written above.

---

| | |
|:---|:---|
| NANO DIMENSION TECHNOLOGIES LTD | NANO DIMENSION TECHNOLOGIES LTD |
| By: | /s/ David Stehlin |
| Name: | David Stehlin |
| Title: | Chief Executive Officer |
| INSPIRA TECHNOLOGIES OXY B.H.N. LTD. | INSPIRA TECHNOLOGIES OXY B.H.N. LTD. |
| By: | /s/ Dagi Ben-Noon |
| Name: | Dagi Ben-Noon |
| Title: | Chief Executive Officer |

---

*[NNDM – Inspira APA Execution Page]*

 

**Annex 1.1.11 Customer Advances** 

**Annex 2.1** - Master list of Purchased Assets

**Annex 2.1.1** - Transferred Intellectual Property and Proprietary Software

**Annex 2.1.1.1** - Transferred Third Party Software

**Annex 2.1.2** - Equipment, Tooling, Books and Records

**Annex 2.1.3** - Inventory

**Annex 2.1.4** - Transferred Contracts

**Annex 2.1.5** - Accounts Receivable

**Annex 2.1.6** - Transferred Leasehold

**Annex 2.3** - Excluded Assets

**Annex 2.2.3** - IIA / Yissum / Governmental Liabilities

**Annex 2.3.8** - Additional Excluded Assets

**Annex 6.5** - Transaction Public Announcement

**Annex 7.3** - Temporary Transition Arrangement Assets

**Annex 7.4** - Rights under nondisclosure, non-competition, non-solicitation and assignment agreements assigned to Buyer (if any)

**Schedule 9** – Disclosure Schedule

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

**Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension** 

 

*The transaction includes intellectual property, customer-related assets and commercial operations, positioning the Company for the next stage of its strategy.*

 

*Further strategic update to follow shortly*

RA'ANANA, Israel, April 6, 2026 — Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), today announced the acquisition of Nano Dimension Ltd.'s (Nasdaq: NNDM) ("Nano Dimension") AME platform.

The acquired platform includes intellectual property, proprietary high-precision 3D electronic printing systems, patented software, engineering know-how, manufacturing equipment, inventory, customer-related assets, and fully equipped facilities, including physics and chemistry laboratories and an ink manufacturing plant. Inspira has assumed control of the acquired assets and operations effective immediately.

The AME technology is a multi-material additive manufacturing platform capable of printing 3D electronic layers with micro-scale precision, supported by specialized engineering know-how. The platform is well-suited for next-generation, high-value electronic applications that demand complex architectures, material integration, and robust performance under highly demanding operating conditions.

The total consideration payable to Nano Dimension in connection with the transaction is up to $12.5 million, consisting of a $2.0 million upfront cash payment, and up to $10.5 million of deferred payments tied to the future performance of the platform over the next twelve months. Completion of the transaction remains subject only to the receipt of customary regulatory approvals.

Dagi Ben-Noon, Chief Executive Officer of Inspira, commented: "From my in-depth knowledge of the AME technology, this acquisition gives Inspira immediate control over a highly specialized advanced-manufacturing platform with proven infrastructure, engineering depth and production capabilities already in place. These assets can now be directed toward high-value applications that align with the next stage of the Company's strategy."

As previously disclosed, Inspira intends to place its existing medical business activities into a wholly owned subsidiary. Those medical operations will continue independently and are not being sold, discontinued or replaced as a part of this transaction.

The Company intends to provide an additional strategic update shortly.

**About Inspira Technologies**

Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The Company's FDA-cleared INSPIRA™ ART100 system is approved for cardiopulmonary bypass in the U.S. and ECMO (Extracorporeal Membrane Oxygenation) procedures outside the U.S and serves as a foundation for the development of the INSPIRA ART500, a next-generation system designed to deliver oxygenation while patients remain awake and spontaneously breathing. Inspira Technologies is also advancing HYLA™, a proprietary blood sensor platform offering continuous, non-invasive monitoring. With multiple cleared products, a growing IP portfolio, and strategic streamlining of its operations, Inspira Technologies is increasingly positioned as an attractive platform within the life-support and MedTech landscape. For more information, visit: https://inspira-technologies.com

**About Nano Dimension Ltd.**

Driven by strong trends in onshoring, national security, and increasing product customization, Nano Dimension Ltd. (Nasdaq: NNDM) delivers advanced Digital Manufacturing technologies to the defense, aerospace, automotive, electronics, and medical devices industries, enabling rapid deployment of high-mix, low-volume production with IP security and sustainable manufacturing practices. For more information, please visit https://www.nano-di.com/

**Forward-Looking Statement Disclaimer**

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the expected closing of the transaction and the anticipated timing thereof, the potential benefits of the acquisition and the capabilities of the acquired business, the Company's ability to integrate the acquired operations and assets, the potential purchase price of the acquired business, the Company's intention to place its existing medical business activities into a wholly owned subsidiary and the Company's strategy. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website at www.sec.gov.

**Company Contact**

Inspira Technologies<br> Email: info@inspirao2.com<br> Phone: +972-9-9664485

**Investor Relations Contact**

Arx Investor Relations<br> North American Equities Desk<br> inspira@arxhq.com

**Nano Dimension Contact:**

Investors: Purva Sanariya

Director, Investor Relations

ir@nano-di.com

Media: Samuel Manning

Principal Manager, External Communications

press@nano-di.com